Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Equity, ethics and the promise of partnership in genomic medicine

Nature Genetics volume 57, pages 765–766 (2025)Cite this article

Subjects

Access through your institution
Buy or subscribe

A recent New York Times article1 highlights a pivotal moment for genetic research: a first revenue-sharing agreement between a biotech company, Variant Bio, and the communities with whom they partner to collect genomic data. Their attempt to address the systemic inequities and historical exploitation that has characterized genomic science raises important questions about how the field can responsibly and feasibly build on this first step.

Although underrepresented in genetic research, data from Indigenous and minoritized communities have propelled several important scientific discoveries2,3. However, these contributions have been historically characterized by a lack of informed consent, exclusion from decision-making, and inequitable distribution of benefits. Variant Bio aims to address this through community engagement, allocating up to 10% of project budgets to community programs and sharing 4% of their annual revenue, as well as seeking to make resulting medications affordable for these communities.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Borrell, B. New York Times https://go.nature.com/4kgEnJd (7 January 2025).

  2. Huisman, L.-A. et al. J. Genet. Couns. 29, 562–573 (2020).

    Article  PubMed  Google Scholar 

  3. Loh, L. et al. Cell 187, 7008–7024.e19 (2024).

    Article  PubMed  Google Scholar 

  4. Minster, R. L. et al. Nat. Genet. 48, 1049–1054 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Rivara, A. C. et al. PLoS ONE 18, e0295845 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hawley, N. L. et al. Obesity (Silver Spring) 32, 1833–1843 (2024).

    Article  PubMed  Google Scholar 

  7. Ah-Hi, E. Samoa Observer https://go.nature.com/4hVScLn (10 November 2017).

Download references

Author information

Authors and Affiliations

  1. Yale School of Public Health, New Haven, CT, USA

    Nicola L. Hawley

  2. Oceania University of Medicine, Apia, Samoa

    Satupaitea Viali

Authors
  1. Nicola L. Hawley
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Satupaitea Viali
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding authors

Correspondence to Nicola L. Hawley or Satupaitea Viali.

Ethics declarations

Competing interests

The authors have no competing interests to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hawley, N.L., Viali, S. Equity, ethics and the promise of partnership in genomic medicine. Nat Genet 57, 765–766 (2025). https://doi.org/10.1038/s41588-025-02131-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41588-025-02131-3

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy